Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL

Autor: Torsten Haferlach, Nicole Weit, Elena Vasyutina, Sebastian Newrzela, Giuliano Crispatzu, Bhagwan Yadav, Georg Hopfinger, Peter Nürnberg, Marc-Henri Stern, Till Braun, Sebastian Oberbeck, Hans Christian Reinhardt, Richard Moriggl, T H Brümmendorf, S. Pützer, Kathrin Warner, Petra Mayer, Satu Mustjoki, Fabian Beier, J. von Jan, Peter Frommolt, Kojo S.J. Elenitoba-Johnson, Shan Zha, Stephan Stilgenbauer, Natali Pflug, Martin Peifer, Alexandra Schrader, Carmen D. Herling, Barry J. Maurer, Mark C. Lanasa, Emma I. Andersson, Marco Herling, Arina Riabinska, Michael Hallek, Janine Altmüller, M. S. Ventura Ferreira
Přispěvatelé: Faculty of Medicine, Medicum, Department of Clinical Chemistry and Hematology, Clinicum, Hematologian yksikkö, University of Helsinki, Department of Oncology, HUS Comprehensive Cancer Center
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Male
0301 basic medicine
Genome instability
General Physics and Astronomy
Ataxia Telangiectasia Mutated Proteins
Kaplan-Meier Estimate
Epigenesis
Genetic

lcsh:Science
Multidisciplinary
CELL PROLYMPHOCYTIC LEUKEMIA
ATM KINASE-ACTIVITY
Middle Aged
EMBRYONIC LETHALITY
Histone
Female
Technology Platforms
Adult
DNA damage
Science
3122 Cancers
Mice
Transgenic

ACUTE MYELOID-LEUKEMIA
Biology
TELOMERASE ACTIVITY
Article
General Biochemistry
Genetics and Molecular Biology

03 medical and health sciences
DOUBLE-STRAND BREAK
Cell Line
Tumor

Proto-Oncogene Proteins
medicine
Animals
Humans
Epigenetics
ATAXIA-TELANGIECTASIA
Aged
CHRONIC LYMPHOCYTIC-LEUKEMIA
Gene Expression Profiling
General Chemistry
medicine.disease
Telomere
Gene expression profiling
HEK293 Cells
030104 developmental biology
DNA-DAMAGE
Leukemia
Prolymphocytic
T-Cell

Mutation
Ataxia-telangiectasia
biology.protein
Cancer research
lcsh:Q
3111 Biomedicine
DNA Damage
GENOMIC INSTABILITY
Zdroj: Nature Communications 9, 697 (2018). doi:10.1038/s41467-017-02688-6
Nature Communications
Nature Communications, Vol 9, Iss 1, Pp 1-22 (2018)
Popis: T-cell prolymphocytic leukemia (T-PLL) is a rare and poor-prognostic mature T-cell malignancy. Here we integrated large-scale profiling data of alterations in gene expression, allelic copy number (CN), and nucleotide sequences in 111 well-characterized patients. Besides prominent signatures of T-cell activation and prevalent clonal variants, we also identify novel hot-spots for CN variability, fusion molecules, alternative transcripts, and progression-associated dynamics. The overall lesional spectrum of T-PLL is mainly annotated to axes of DNA damage responses, T-cell receptor/cytokine signaling, and histone modulation. We formulate a multi-dimensional model of T-PLL pathogenesis centered around a unique combination of TCL1 overexpression with damaging ATM aberrations as initiating core lesions. The effects imposed by TCL1 cooperate with compromised ATM toward a leukemogenic phenotype of impaired DNA damage processing. Dysfunctional ATM appears inefficient in alleviating elevated redox burdens and telomere attrition and in evoking a p53-dependent apoptotic response to genotoxic insults. As non-genotoxic strategies, synergistic combinations of p53 reactivators and deacetylase inhibitors reinstate such cell death execution.
T-cell prolymphocytic leukemia (T-PLL) is a rare malignancy with a poor prognosis. Here, the authors investigate the genomic landscape, gene expression profiles and functional mechanisms in 111 patients, highlighting TCL1 overexpression and ATM aberrations as core lesions which co-operate to impair DNA damage processing.
Databáze: OpenAIRE